Trinity Biotech (Primus Corporation dba Trinity Biotech)
1 recall(s) on record — most severe on record: Class II.
Activity by year
- Recalls (1)
- Inspections (4)
- Warning letters (1)
Devices registered here (1)
- Assay, Glycosylated HemoglobinProduct code LCP (opens in a new tab) · Class II · Hematology · 21 CFR 864.7470
Recalls & enforcement
- Class IIOngoing2025-07-22Potential for Bartels ELISA Legionella Urinary Antigen kit B1029-440 lot 065 and 066 to contain particulate matter.
FDA inspections (4)
- NAI2022-09-26No Action Indicated · Compliance: Devices; Postmarket Assurance: Devices
- NAI2021-09-17No Action Indicated · Compliance: Devices; Postmarket Assurance: Devices
- OAI2020-02-06Official Action Indicated · Compliance: Devices · citations posted
- OAI2018-09-06Official Action Indicated · Compliance: Devices; Postmarket Assurance: Devices · citations posted
Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.
FDA warning letters (1)
- Warning Letter2020-08-12Warning Letter (opens in a new tab) · Kansas City Missouri
Source: U.S. FDA Compliance Actions Dashboard (opens in a new tab) (device warning letters, 2016–present). Data as of 2026-10-06. Each link opens an FDA search for the letter; FDA can take several weeks to post a letter, so a very recent one may not appear yet.
Related
- All facilities operated by TRINITY BIOTECH, PLC
- TRINITY BIOTECH, PLC (IE)
- Trinity Biotech USA (NY)
- Trinity Biotech do Brasil (BR)
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)
Cite this record
RegWarden. “Trinity Biotech (Primus Corporation dba Trinity Biotech) (FEI 1931251) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/1931251-trinity-biotech-primus-corporation-dba-t/
Alerts for Trinity Biotech (Primus Corporation dba Trinity Biotech)
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.